Empower Your Research with Advanced Solutions
At VisaThera, we are dedicated to pushing the boundaries of biotechnology. Our cutting-edge research and development initiatives are aimed at advancing the field of drug discovery and development for the benefit of humanity.
- Designing novel molecules using AI-driven computational tools
- Integrating in silico, in vitro, and in vivo workflows
- Developing targeted therapies for high-priority diseases
What Makes VisaThera Deep-Tech?
- India’s first marine-bioactives + AI discovery platform
- Proprietary phlorotannin database (>100 molecules)
- Focus on challenging enzyme targets ignored by conventional chemical libraries
- Custom AI model trained on natural-product chemotypesIntegration of MD, FEP+, QSAR, and generative AI
- Ability to move from digital hit → validated lead → formulation prototype within months
- Affordable Indian-built computational drug discovery at global standards
EXPLORE OUR MAIN SERVICES
→ Specialized consultancy services supporting drug discovery and development projects at any stage.
→ Facilitation of collaborations and partnerships with both academic institutions and industrial entities for integrated drug discovery programs.
→ Assistance in grant proposal writing, strategic project planning, and regulatory guidance for early-stage pharmaceutical projects.
→ Utilization of advanced analytical techniques such as Nuclear Magnetic Resonance (NMR), High-Resolution Mass Spectrometry (HRMS), and High-Performance Liquid Chromatography (HPLC) for structural and purity assessment.
→ Structural elucidation and detailed physicochemical property profiling of compounds.
→ High-standard quality control ensuring integrity and accuracy in data reporting.
→ Comprehensive development of robust biochemical and cell-based assays for evaluating therapeutic efficacy and potency.
→ Enzyme inhibition assays tailored to assess compound specificity and activity.
→ Validation protocols designed to meet international regulatory standards, ensuring reproducibility and accuracy of assay results.
→ Development of novel assays for new and challenging therapeutic targets.
→ Custom-designed synthesis routes tailored to meet specific client requirements.
→ Efficient multi-step organic synthesis, including complex molecule synthesis and lead optimization.
→ Expertise in scalable synthetic methodologies, route optimization, and process development suitable for preclinical and early clinical phases.
→ Full analytical characterization of synthesized compounds to ensure purity and consistency.
→ Advanced molecular docking for precise ligand-target interactions.
→ Pharmacophore modeling to identify key molecular features essential for biological activity.
→ Molecular dynamics simulations providing insights into molecular stability and behavior over time.
→ Quantitative Structure-Activity Relationship (QSAR) modeling to predict biological activity of novel compounds.
→ Expertise in both ligand-based and structure-based approaches to efficiently design potent therapeutic candidates.
Advisors – R&D and Innovation
Prof. Asad U. Khan brings over 30 years of research experience in Microbiology, with a strong focus on antimicrobial resistance and infection control. He has published more than 250 research articles in peer-reviewed journals and has developed a patented laser-based photodynamic technology for the treatment of diabetic foot ulcers. Prof. Khan has served on numerous national and international task-force committees for project evaluation. His work, particularly the discovery of the NDM-4 superbug, has been widely featured in national and international print and electronic media. He is the recipient of several prestigious awards and recognitions from both national and international bodies, including one conferred by the Hon’ble President of India.